Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China; The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, Canada; Department of Computer Science, University of Toronto, Toronto, ON, Canada.
EBioMedicine. 2019 Feb;40:564-573. doi: 10.1016/j.ebiom.2019.01.023. Epub 2019 Feb 8.
Background Tuberculosis (TB) is difficult to diagnose under complex clinical conditions as electronic health records (EHRs) are often inadequate in making an affirmative diagnosis. As exosomal miRNAs emerged as promising biomarkers, we investigated the potential of using exosomal miRNAs and EHRs in TB diagnosis.
A total of 370 individuals, including pulmonary tuberculosis (PTB), tuberculous meningitis (TBM), non-TB disease controls and healthy state controls, were enrolled. Exosomal miRNAs were profiled in the exploratory cohort using microarray and miRNA candidates were selected in the selection cohort using qRT-PCR. EHRs and follow-up information of the patients were collected accordingly. miRNAs and EHRs were used to develop diagnostic models for PTB and TBM in the selection cohort with the Support Vector Machine (SVM) algorithm. These models were further evaluated in an independent testing cohort.
Six exosomal miRNAs (miR-20a, miR-20b, miR-26a, miR-106a, miR-191, miR-486) were differentially expressed in the TB patients. Three SVM models, "EHR+miRNA", "miRNA only" and "EHR only" were compared, and "EHR + miRNA" model achieved the highest diagnostic efficacy, with an AUC up to 0.97 (95% CI 0.80-0.99) in TBM and 0.97 (0.87-0.99) in PTB, respectively. However, "EHR only" model only showed an AUC of 0.67 (0.46-0.83) in TBM. After 2-month anti-tuberculosis therapy, overexpressed miRNAs presented a decreased expression trend (p= 4.80 × 10).
Our results showed that the combination of exosomal miRNAs and EHRs could potentially improve clinical diagnosis of TBM and PTB. FUND: Funds for the Central Universities, the National Natural Science Foundation of China.
背景 电子病历(EHRs)在做出明确诊断方面往往不够充分,因此在复杂的临床情况下,结核病(TB)的诊断较为困难。由于外泌体 miRNA 已成为很有前途的生物标志物,我们研究了使用外泌体 miRNA 和 EHRs 进行 TB 诊断的潜力。
共纳入 370 例个体,包括肺结核(PTB)、结核性脑膜炎(TBM)、非 TB 疾病对照组和健康对照组。在探索性队列中使用微阵列对细胞外体 miRNA 进行了分析,并使用 qRT-PCR 在选择队列中选择了 miRNA 候选物。相应地收集了患者的 EHR 和随访信息。使用支持向量机(SVM)算法在选择队列中使用 miRNA 和 EHR 为 PTB 和 TBM 开发诊断模型。在独立测试队列中进一步评估了这些模型。
6 种外泌体 miRNA(miR-20a、miR-20b、miR-26a、miR-106a、miR-191、miR-486)在 TB 患者中表达差异。比较了 3 种 SVM 模型,“EHR+miRNA”、“miRNA 仅”和“EHR 仅”,“EHR+miRNA”模型在 TBM 中诊断效能最高,AUC 高达 0.97(95%CI 0.80-0.99),在 PTB 中为 0.97(0.87-0.99)。然而,“EHR 仅”模型在 TBM 中仅显示 AUC 为 0.67(0.46-0.83)。经过 2 个月的抗结核治疗,过表达 miRNA 呈现出降低的表达趋势(p=4.80×10)。
我们的结果表明,外泌体 miRNA 和 EHRs 的结合可能有助于提高 TBM 和 PTB 的临床诊断。
中央高校基本科研业务费专项资金,国家自然科学基金。